Industries > Pharma > Autotransfusion Systems Market Report to 2031
Autotransfusion Systems Market Report to 2031
By Type (Autotransfusion Types, Autotransfusion Accessories, Gastric Balloons), By Application (Trauma Procedures, Orthopedic Surgeries, Organ Transplantation, Cardiac Surgeries, Others), and Leading Regional/ Country Market Analysis
Global Autotransfusion Systems Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Global Autotransfusion Systems market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our Global Autotransfusion Systems 254 page report provides 208 tables and 178 charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Global Autotransfusion Systems Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analysis (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and recent developments.
Discover sales predictions for the world market and submarkets
Global Autotransfusion Systems: By Type
• Autotransfusion Types
• Autotransfusion Accessories
Global Autotransfusion Systems: By Application
• Trauma Procedures
• Orthopedic Surgeries
• Organ Transplantation
• Cardiac Surgeries
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Global Autotransfusion Systems Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Global Autotransfusion Systems Market will surpass $XXX million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Global Autotransfusion Systems Market report helps you
In summary, our 250+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Global Autotransfusion Systems Market, with forecasts for Type, Application, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Global Autotransfusion Systems market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for Global Autotransfusion Systems of the major companies involved in the Global Autotransfusion Systems Market. Some of the company’s profiled in this report are Becton, Dickinson and Company, Medtronic PLC, Zimmer Biomet Holdings, Inc, LivaNova, Fresenius, Atrium Medical Corporation, Teleflex Inc, Haemonetics Corporation, Sarstedt, Inc., among others.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Global Autotransfusion Systems Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Autotransfusion Systems Market Report to 2031: By Type (Autotransfusion Types, Autotransfusion Accessories, Gastric Balloons), By Application (Trauma Procedures, Orthopedic Surgeries, Organ Transplantation, Cardiac Surgeries, Others), and Leading Regional/ Country Market Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Autotransfusion Systems Market
2.1. Autotransfusion Systems Market Definition
2.2. Type Submarkets Definitions
2.3. Applications Submarkets Definitions
3. Autotransfusion Systems Market Overview
3.1. Global Autotransfusion Systems Market Size and Forecast by Region
3.2. Global Autotransfusion Systems Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising incidence and prevalence rate of fatal diseases
3.3.1.2. Increasing surgeries around the globe
3.3.1.3. Growing adoption of robotic surgeries
3.3.1.4. Lack of Donated Blood/Allogenic Blood
3.3.1.5. Technological Advancement and innovation
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost
3.3.2.2. Risks Associated in the Autotransfusion
3.3.2.3. Low awareness
3.3.3. Opportunities
3.3.3.1. Cohesive government policies
3.3.3.2. Untapped emerging economies will create opportunities
3.3.3.3. Rising disposable income in emerging economies
3.3.3.4. Rising healthcare spending around the world
4. Global Autotransfusion Systems Market Analysis and Forecast 2021-2031, by Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Autotransfusion Types
4.1.1.1. Intraoperative Autotransfusion Systems
4.1.1.2. Postoperative Autotransfusion Systems
4.1.1.3. Dual-Mode Autotransfusion Systems
4.1.2. Autotransfusion Accessories
5. Global Autotransfusion Systems Market Analysis and Forecast, 2021-2031 by Applications (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Trauma Procedures
5.1.2. Orthopedic Surgeries
5.1.3. Organ Transplantation
5.1.4. Cardiac Surgeries
5.1.5. Others
6. North America Autotransfusion Systems Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Autotransfusion Systems Market Size and Forecast by Type
6.3. North America Autotransfusion Systems Market Size and Forecast by Applications
6.4. U.S. Autotransfusion Systems Market
6.4.1. Increasing surgeries and adoption of robotics
6.5. Canada Autotransfusion Systems Market
6.5.1. Rising adoption of hybrid operating rooms for surgeries
7. Europe Autotransfusion Systems Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Autotransfusion Systems Market Size and Forecast by Type
7.3. Europe Autotransfusion Systems Market Size and Forecast by Applications
7.4. UK Autotransfusion Systems Market
7.5. Germany Autotransfusion Systems Market
7.6. France Autotransfusion Systems Market
7.7. Rest of Europe Autotransfusion Systems Market
8. Asia Pacific Autotransfusion Systems Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Autotransfusion Systems Market Size and Forecast by Type
8.3. Asia Pacific Autotransfusion Systems Market Size and Forecast by Applications
8.4. China Autotransfusion Systems Market
8.5. India Autotransfusion Systems Market
8.6. Japan Autotransfusion Systems Market
8.7. Rest of Asia Pacific Autotransfusion Systems Market
9. Latin America Autotransfusion Systems Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Autotransfusion Systems Market Size and Forecast by Type
9.3. Latin America Autotransfusion Systems Market Size and Forecast by Applications
9.3.1. Brazil Autotransfusion Systems Market
9.3.2. Mexico Autotransfusion Systems Market
9.3.3. Rest of Latin America Autotransfusion Systems Market
10. MEA Autotransfusion Systems Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Autotransfusion Systems Market Size and Forecast by Type
10.3. MEA Autotransfusion Systems Market Size and Forecast by Applications
10.4. GCC Autotransfusion Systems Market
10.5. South Africa Autotransfusion Systems Market
10.6. Rest of MEA Autotransfusion Systems Market
11. Companies in the Autotransfusion Systems Market
11.1. Becton, Dickinson and Company
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial (2016-2019)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2019
11.1.4. Product Offerings
11.1.5. Recent Initiatives (2017-2019)
11.2. Medtronic PLC
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2019)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2019
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2019)
11.3. Zimmer Biomet Holdings, Inc
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2019)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2019
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2019)
11.4. LivaNova
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2019)
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue, 2019
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2019)
11.5. Fresenius
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2019)
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue, 2019
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2019)
11.6. Atrium Medical Corporation
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2019)
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue, 2019
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2019)
11.7. Teleflex Incorporated
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2019)
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue, 2019
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2019)
11.8. Haemonetics Corporation
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2019)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue, 2019
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2019)
11.9. Sarstedt, Inc.
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2019)
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue, 2019
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2019)
11.10. Braile Biomédica
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2019)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue, 2019
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2019)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order procedure
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation procedure
LIST OF TABLES
Table 1. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Autotransfusion Systems Market Drivers & Restraints 2020
Table 7. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 13. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 23. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 63. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 64. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 65. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 66. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 67. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 88. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Leading 10 Autotransfusion Systems Market Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 183. Becton, Dickinson and Company Profile 2019 (CEO, HQ, Founded, Website)
Table 184. Becton, Dickinson and Company Autotransfusion Systems Recent Developments
Table 185. Becton, Dickinson and Company Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 186. Medtronic PLC Profile 2019 (CEO, HQ, Founded, Website)
Table 187. Medtronic PLC Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 188. Zimmer Biomet Holdings, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 189. Zimmer Biomet Holdings, Inc Autotransfusion Systems Recent Developments
Table 190. Zimmer Biomet Holdings, Inc Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 191. LivaNova Profile 2019 (CEO, HQ, Founded, Website)
Table 192. LivaNova Autotransfusion Systems Recent Developments
Table 193. LivaNova Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 194. Fresenius Profile 2019 (CEO, HQ, Founded, Website)
Table 195. Fresenius Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 196. Atrium Medical Corporation Company Profile 2019 (CEO, HQ, Founded, Website)
Table 197. Atrium Medical Corporation Company Optic Network Recent Developments
Table 198. Atrium Medical Corporation Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 199. Teleflex Incorporated Profile 2019 (CEO, HQ, Founded, Website)
Table 200. Teleflex Incorporated Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 201. Haemonetics Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 202. Haemonetics Corporation Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 203. Sarstedt, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 204. Sarstedt, Inc. Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 205. Braile Biomédica Profile 2019 (CEO, Total Company Sales US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 206. Braile Biomédica Total Company Sales 2015-2019 (US$m, AGR %)
Table 207. Braile Biomédica Sales by Segment of Business 2019 (US$m)
Table 208. Other Companies Involved in the Autotransfusion Systems Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1. Autotransfusion Systems Market Type Overview
Figure 2. Autotransfusion Systems Market Applications Overview
Figure 3. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 4. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 5. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 6. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 7. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 8. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 9. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 10. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 11. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 12. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 13. Autotransfusion Types Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 14. Autotransfusion Types Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 15. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 16. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 17. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 18. Autotransfusion Accessories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 19. Autotransfusion Accessories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 20. Autotransfusion Accessories Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 21. Autotransfusion Accessories Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 22. Autotransfusion Accessories Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 29. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 30. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 31. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 32. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 33. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 34. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 35. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 36. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 37. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 38. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 39. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 40. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 41. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 42. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 38. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 39. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 40. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 41. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 42. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 43. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 44. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 45. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 46. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 47. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 48. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 49. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 50. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 51. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 52. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 53. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 54. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 55. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 56. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 57. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 58. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 59. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 60. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 61. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 62. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 63. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (Before COVID)
Figure 64. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 65. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 66. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 67. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 68. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 69. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 70. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 71. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 72. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 73. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 74. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 75. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 76. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 77. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 78. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 79. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 80. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 81. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 82. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 83. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M)
Figure 84. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 85. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 86. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 87. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 88. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 89. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 90. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 91. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 92. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 93. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 94. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 95. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 96. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 97. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 98. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 99. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 100. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 101. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 102. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 103. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 104. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 105. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 106. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 107. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 108. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 109. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 110. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 111. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 112. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 113. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 114. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 115. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 116. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 117. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 118. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 119. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 120. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 121. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 122. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 123. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 124. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 125. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 126. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 127. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 128. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 129. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 130. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 131. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 132. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 133. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 134. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 135. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 136. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 137. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 138. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 139. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 140. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 141. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 142. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 143. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 144. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 145. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 146. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 147. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 148. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M)
Figure 149. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 150. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 151. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 152. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 153. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 154. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 155. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 156. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 157. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 158. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M)
Figure 159. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 160. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 161. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 162. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 163. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 164. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 165. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 166. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 167. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 168. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M)
Figure 169. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 170. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 171. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 172. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 173. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 174. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 175. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 176. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 177. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 178. Porter’s Five Force Analysis
Companies Mentioned
1. Becton, Dickinson and Company
2. Medtronic PLC
3. Zimmer Biomet Holdings, Inc
4. LivaNova
5. Fresenius
6. Allergan, Inc.
7. Teleflex Incorporated
8. Haemonetics Corporation
9. Atrium Medical Corporation
10. Reshape Lifesciences
11. Mediflex Surgical Products
12. Covidien PLC
13. Sarstedt, Inc.
14. Braile Biomédica
15. Neurogene Inc.
16. Celgene Corp
17. Abbott Laboratories
18. Teva Pharmaceuticals
19. Pfizer, Inc.
20. F. Hoffman-La Roche AG
21. Bristol-Myers Squibb Company
22. Eli Lilly and Company
23. Novartis AG
24. Kyowa Hakko Kirin Co Ltd.
25. Intercept Pharmaceuticals, Inc.
26. Accord Healthcare Inc.
27. Delcath Systems Inc.
28. Johnson & Johnson
29. AbbVie
30. Amgen
31. Astellas Pharma
32. AstraZeneca
33. Aurora Biophama
34. Boehringer Ingelheim
35. Gilead
36. GlaxoSmithKline (GSK)
37. GE Healthcare
38. Corvus Pharmaceuticals
39. Daiichi-Sankyo
40. Agency for Medical Innovation
41. Endogastric Solutions Inc.
42. GI Dynamics Inc.
43. TransEnterix Inc.
44. Mediflex Surgical Applicationss.
45. Danaher Corporation
46. Baxter International
47. 3M company
48. Stryker Corporation
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Autotransfusion Systems Market
2.1. Autotransfusion Systems Market Definition
2.2. Type Submarkets Definitions
2.3. Applications Submarkets Definitions
3. Autotransfusion Systems Market Overview
3.1. Global Autotransfusion Systems Market Size and Forecast by Region
3.2. Global Autotransfusion Systems Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising incidence and prevalence rate of fatal diseases
3.3.1.2. Increasing surgeries around the globe
3.3.1.3. Growing adoption of robotic surgeries
3.3.1.4. Lack of Donated Blood/Allogenic Blood
3.3.1.5. Technological Advancement and innovation
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost
3.3.2.2. Risks Associated in the Autotransfusion
3.3.2.3. Low awareness
3.3.3. Opportunities
3.3.3.1. Cohesive government policies
3.3.3.2. Untapped emerging economies will create opportunities
3.3.3.3. Rising disposable income in emerging economies
3.3.3.4. Rising healthcare spending around the world
4. Global Autotransfusion Systems Market Analysis and Forecast 2021-2031, by Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Autotransfusion Types
4.1.1.1. Intraoperative Autotransfusion Systems
4.1.1.2. Postoperative Autotransfusion Systems
4.1.1.3. Dual-Mode Autotransfusion Systems
4.1.2. Autotransfusion Accessories
5. Global Autotransfusion Systems Market Analysis and Forecast, 2021-2031 by Applications (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Trauma Procedures
5.1.2. Orthopedic Surgeries
5.1.3. Organ Transplantation
5.1.4. Cardiac Surgeries
5.1.5. Others
6. North America Autotransfusion Systems Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Autotransfusion Systems Market Size and Forecast by Type
6.3. North America Autotransfusion Systems Market Size and Forecast by Applications
6.4. U.S. Autotransfusion Systems Market
6.4.1. Increasing surgeries and adoption of robotics
6.5. Canada Autotransfusion Systems Market
6.5.1. Rising adoption of hybrid operating rooms for surgeries
7. Europe Autotransfusion Systems Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Autotransfusion Systems Market Size and Forecast by Type
7.3. Europe Autotransfusion Systems Market Size and Forecast by Applications
7.4. UK Autotransfusion Systems Market
7.5. Germany Autotransfusion Systems Market
7.6. France Autotransfusion Systems Market
7.7. Rest of Europe Autotransfusion Systems Market
8. Asia Pacific Autotransfusion Systems Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Autotransfusion Systems Market Size and Forecast by Type
8.3. Asia Pacific Autotransfusion Systems Market Size and Forecast by Applications
8.4. China Autotransfusion Systems Market
8.5. India Autotransfusion Systems Market
8.6. Japan Autotransfusion Systems Market
8.7. Rest of Asia Pacific Autotransfusion Systems Market
9. Latin America Autotransfusion Systems Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Autotransfusion Systems Market Size and Forecast by Type
9.3. Latin America Autotransfusion Systems Market Size and Forecast by Applications
9.3.1. Brazil Autotransfusion Systems Market
9.3.2. Mexico Autotransfusion Systems Market
9.3.3. Rest of Latin America Autotransfusion Systems Market
10. MEA Autotransfusion Systems Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Autotransfusion Systems Market Size and Forecast by Type
10.3. MEA Autotransfusion Systems Market Size and Forecast by Applications
10.4. GCC Autotransfusion Systems Market
10.5. South Africa Autotransfusion Systems Market
10.6. Rest of MEA Autotransfusion Systems Market
11. Companies in the Autotransfusion Systems Market
11.1. Becton, Dickinson and Company
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial (2016-2019)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2019
11.1.4. Product Offerings
11.1.5. Recent Initiatives (2017-2019)
11.2. Medtronic PLC
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2019)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2019
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2019)
11.3. Zimmer Biomet Holdings, Inc
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2019)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2019
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2019)
11.4. LivaNova
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2019)
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue, 2019
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2019)
11.5. Fresenius
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2019)
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue, 2019
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2019)
11.6. Atrium Medical Corporation
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2019)
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue, 2019
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2019)
11.7. Teleflex Incorporated
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2019)
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue, 2019
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2019)
11.8. Haemonetics Corporation
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2019)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue, 2019
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2019)
11.9. Sarstedt, Inc.
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2019)
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue, 2019
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2019)
11.10. Braile Biomédica
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2019)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue, 2019
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2019)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order procedure
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation procedure
LIST OF TABLES
Table 1. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Autotransfusion Systems Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Autotransfusion Systems Market Drivers & Restraints 2020
Table 7. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 13. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Autotransfusion Accessories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 23. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Trauma Procedures Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Organ Transplantation Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Cardiac Surgeries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Regional Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 63. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 64. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 65. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 66. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 67. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 88. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Asia Pacific Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Asia Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Asia Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. RoAPAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Leading 10 Autotransfusion Systems Market Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 183. Becton, Dickinson and Company Profile 2019 (CEO, HQ, Founded, Website)
Table 184. Becton, Dickinson and Company Autotransfusion Systems Recent Developments
Table 185. Becton, Dickinson and Company Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 186. Medtronic PLC Profile 2019 (CEO, HQ, Founded, Website)
Table 187. Medtronic PLC Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 188. Zimmer Biomet Holdings, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 189. Zimmer Biomet Holdings, Inc Autotransfusion Systems Recent Developments
Table 190. Zimmer Biomet Holdings, Inc Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 191. LivaNova Profile 2019 (CEO, HQ, Founded, Website)
Table 192. LivaNova Autotransfusion Systems Recent Developments
Table 193. LivaNova Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 194. Fresenius Profile 2019 (CEO, HQ, Founded, Website)
Table 195. Fresenius Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 196. Atrium Medical Corporation Company Profile 2019 (CEO, HQ, Founded, Website)
Table 197. Atrium Medical Corporation Company Optic Network Recent Developments
Table 198. Atrium Medical Corporation Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 199. Teleflex Incorporated Profile 2019 (CEO, HQ, Founded, Website)
Table 200. Teleflex Incorporated Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 201. Haemonetics Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 202. Haemonetics Corporation Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 203. Sarstedt, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 204. Sarstedt, Inc. Autotransfusion Systems Product Offering (Segment, Product Offerings)
Table 205. Braile Biomédica Profile 2019 (CEO, Total Company Sales US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 206. Braile Biomédica Total Company Sales 2015-2019 (US$m, AGR %)
Table 207. Braile Biomédica Sales by Segment of Business 2019 (US$m)
Table 208. Other Companies Involved in the Autotransfusion Systems Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1. Autotransfusion Systems Market Type Overview
Figure 2. Autotransfusion Systems Market Applications Overview
Figure 3. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 4. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 5. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 6. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 7. Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 8. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 9. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 10. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 11. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 12. Autotransfusion Systems Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 13. Autotransfusion Types Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 14. Autotransfusion Types Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 15. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 16. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 17. Autotransfusion Types Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 18. Autotransfusion Accessories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 19. Autotransfusion Accessories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 20. Autotransfusion Accessories Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 21. Autotransfusion Accessories Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 22. Autotransfusion Accessories Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 29. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 30. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 31. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 32. Autotransfusion Systems Submarket Forecast by Applications 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 33. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 34. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 35. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 36. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 37. Trauma Procedures Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 38. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 39. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 40. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 41. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 42. Orthopedic Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 38. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 39. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 40. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 41. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 42. Organ Transplantation Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 43. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 44. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 45. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 46. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 47. Cardiac Surgeries Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 48. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 49. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 50. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 51. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 52. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 53. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 54. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 55. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 56. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 57. Regional Autotransfusion Systems Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 58. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 59. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 60. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 61. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 62. North America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 63. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (Before COVID)
Figure 64. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 65. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 66. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 67. North America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 68. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 69. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 70. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 71. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 72. North America Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 73. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 74. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 75. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 76. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 77. US Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 78. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 79. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 80. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 81. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 82. Canada Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 83. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M)
Figure 84. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 85. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 86. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 87. Europe Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 88. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 89. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 90. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 91. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 92. Europe Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 93. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 94. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 95. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 96. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 97. Europe Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 98. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 99. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 100. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 101. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 102. UK Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 103. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 104. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 105. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 106. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 107. Germany Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 108. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 109. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 110. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 111. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 112. France Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 113. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 114. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 115. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 116. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 117. Rest of Europe Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 118. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 119. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 120. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 121. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 122. Asia-Pacific Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 123. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 124. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 125. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 126. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 127. Asia-Pacific Autotransfusion Systems Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 128. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 129. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 130. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 131. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 132. China Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 133. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %)
Figure 134. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 135. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 136. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 137. India Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 138. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 139. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 140. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 141. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 142. Japan Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 143. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 144. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 145. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 146. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 147. Rest of APAC Autotransfusion Systems Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 148. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M)
Figure 149. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 150. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 151. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 152. Middle East Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 153. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 154. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 155. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 156. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 157. Middle East Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 158. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M)
Figure 159. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 160. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 161. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 162. Latin America Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 163. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 164. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 165. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 166. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 167. Latin America Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 168. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M)
Figure 169. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 170. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 171. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 172. Africa Autotransfusion Systems Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 173. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (Before COVID)
Figure 174. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario V)
Figure 175. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario U)
Figure 176. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario W)
Figure 177. Africa Autotransfusion Systems Market Forecast by Applications 2021-2031 (US$M) (COVID - Scenario L)
Figure 178. Porter’s Five Force Analysis
Companies Mentioned
1. Becton, Dickinson and Company
2. Medtronic PLC
3. Zimmer Biomet Holdings, Inc
4. LivaNova
5. Fresenius
6. Allergan, Inc.
7. Teleflex Incorporated
8. Haemonetics Corporation
9. Atrium Medical Corporation
10. Reshape Lifesciences
11. Mediflex Surgical Products
12. Covidien PLC
13. Sarstedt, Inc.
14. Braile Biomédica
15. Neurogene Inc.
16. Celgene Corp
17. Abbott Laboratories
18. Teva Pharmaceuticals
19. Pfizer, Inc.
20. F. Hoffman-La Roche AG
21. Bristol-Myers Squibb Company
22. Eli Lilly and Company
23. Novartis AG
24. Kyowa Hakko Kirin Co Ltd.
25. Intercept Pharmaceuticals, Inc.
26. Accord Healthcare Inc.
27. Delcath Systems Inc.
28. Johnson & Johnson
29. AbbVie
30. Amgen
31. Astellas Pharma
32. AstraZeneca
33. Aurora Biophama
34. Boehringer Ingelheim
35. Gilead
36. GlaxoSmithKline (GSK)
37. GE Healthcare
38. Corvus Pharmaceuticals
39. Daiichi-Sankyo
40. Agency for Medical Innovation
41. Endogastric Solutions Inc.
42. GI Dynamics Inc.
43. TransEnterix Inc.
44. Mediflex Surgical Applicationss.
45. Danaher Corporation
46. Baxter International
47. 3M company
48. Stryker Corporation
Companies Profiled in the Report
1. Becton, Dickinson and Company
2. Medtronic PLC
3. Zimmer Biomet Holdings, Inc
4. LivaNova
5. Fresenius
6. Allergan, Inc.
7. Teleflex Incorporated
8. Haemonetics Corporation
9. Atrium Medical Corporation
10. Reshape Lifesciences
11. Mediflex Surgical Products
12. Covidien PLC
13. Sarstedt, Inc.
List of Companies Mentioned in the Report
1. Becton, Dickinson and Company
2. Medtronic PLC
3. Zimmer Biomet Holdings, Inc
4. LivaNova
5. Fresenius
6. Allergan, Inc.
7. Teleflex Incorporated
8. Haemonetics Corporation
9. Atrium Medical Corporation
10. Reshape Lifesciences
11. Mediflex Surgical Products
12. Covidien PLC
13. Sarstedt, Inc.
14. Braile Biomédica
15. Neurogene Inc.
16. Celgene Corp
17. Abbott Laboratories
18. Teva Pharmaceuticals
19. Pfizer, Inc.
20. F. Hoffman-La Roche AG
21. Bristol-Myers Squibb Company
22. Eli Lilly and Company
23. Novartis AG
24. Kyowa Hakko Kirin Co Ltd.
25. Intercept Pharmaceuticals, Inc.
26. Accord Healthcare Inc.
27. Delcath Systems Inc.
28. Johnson & Johnson
29. AbbVie
30. Amgen
31. Astellas Pharma
32. AstraZeneca
33. Aurora Biophama
34. Boehringer Ingelheim
35. Gilead
36. GlaxoSmithKline (GSK)
37. GE Healthcare
38. Corvus Pharmaceuticals
39. Daiichi-Sankyo
40. Agency for Medical Innovation
41. Endogastric Solutions Inc.
42. GI Dynamics Inc.
43. TransEnterix Inc.
44. Mediflex Surgical Applicationss.
45. Danaher Corporation
46. Baxter International
47. 3M company
48. Stryker Corporation
List of Organizations Mentioned in the Report
1. American Society for Metabolic and Autotransfusion Systems
2. Mayo Clinic
3. Penn Medicine
4. Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
5. University of California San Francisco
6. American College of Surgeons
7. National Institute of Diabetes and Digestive and Kidney Diseases
8. FirstHealth of the Carolinas, Inc.
9. Narayan Health
10. Columbia University Irving Medical Center, Department of Surgery, New York, NY.
11. NCBI (National Center for Biotechnology Information)
12. World Health Organization (WHO)
13. Cancer.org
14. Mayo.edu
15. Rogel cancer center
16. Duke Health
17. BMI Surgery organization
18. Franciscanhealth.org
19. Cleveland Clinic
20. European Commission
21. World Bank
22. Centers for Disease Control and Prevention (CDC)
23. National Institutes of Health (NIH)
1. Becton, Dickinson and Company
2. Medtronic PLC
3. Zimmer Biomet Holdings, Inc
4. LivaNova
5. Fresenius
6. Allergan, Inc.
7. Teleflex Incorporated
8. Haemonetics Corporation
9. Atrium Medical Corporation
10. Reshape Lifesciences
11. Mediflex Surgical Products
12. Covidien PLC
13. Sarstedt, Inc.
List of Companies Mentioned in the Report
1. Becton, Dickinson and Company
2. Medtronic PLC
3. Zimmer Biomet Holdings, Inc
4. LivaNova
5. Fresenius
6. Allergan, Inc.
7. Teleflex Incorporated
8. Haemonetics Corporation
9. Atrium Medical Corporation
10. Reshape Lifesciences
11. Mediflex Surgical Products
12. Covidien PLC
13. Sarstedt, Inc.
14. Braile Biomédica
15. Neurogene Inc.
16. Celgene Corp
17. Abbott Laboratories
18. Teva Pharmaceuticals
19. Pfizer, Inc.
20. F. Hoffman-La Roche AG
21. Bristol-Myers Squibb Company
22. Eli Lilly and Company
23. Novartis AG
24. Kyowa Hakko Kirin Co Ltd.
25. Intercept Pharmaceuticals, Inc.
26. Accord Healthcare Inc.
27. Delcath Systems Inc.
28. Johnson & Johnson
29. AbbVie
30. Amgen
31. Astellas Pharma
32. AstraZeneca
33. Aurora Biophama
34. Boehringer Ingelheim
35. Gilead
36. GlaxoSmithKline (GSK)
37. GE Healthcare
38. Corvus Pharmaceuticals
39. Daiichi-Sankyo
40. Agency for Medical Innovation
41. Endogastric Solutions Inc.
42. GI Dynamics Inc.
43. TransEnterix Inc.
44. Mediflex Surgical Applicationss.
45. Danaher Corporation
46. Baxter International
47. 3M company
48. Stryker Corporation
List of Organizations Mentioned in the Report
1. American Society for Metabolic and Autotransfusion Systems
2. Mayo Clinic
3. Penn Medicine
4. Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
5. University of California San Francisco
6. American College of Surgeons
7. National Institute of Diabetes and Digestive and Kidney Diseases
8. FirstHealth of the Carolinas, Inc.
9. Narayan Health
10. Columbia University Irving Medical Center, Department of Surgery, New York, NY.
11. NCBI (National Center for Biotechnology Information)
12. World Health Organization (WHO)
13. Cancer.org
14. Mayo.edu
15. Rogel cancer center
16. Duke Health
17. BMI Surgery organization
18. Franciscanhealth.org
19. Cleveland Clinic
20. European Commission
21. World Bank
22. Centers for Disease Control and Prevention (CDC)
23. National Institutes of Health (NIH)
Download sample pages
Complete the form below to download your free sample pages for Autotransfusion Systems Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for Autotransfusion Systems Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
